Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» CorMedix (CRMD): Undervalued and Under Investor’s Radar
CorMedix (CRMD): Undervalued and Under Investor’s Radar
CorMedix (CRMD): Undervalued and Under Investor’s Radar
Submitted by
admin
on December 11, 2010 - 12:45pm
Source:
istockanalyst
News Tags:
CorMedix
cardiorenal
Neutrolin
Deferiprone
Contrast Induced-Nephropathy
catheters
Headline:
CorMedix (CRMD): Undervalued and Under Investor’s Radar
Do Not Allow Advertisers to Use My Personal information
